This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Yeh, H.-M. Articles by Lai, L.-P. Search for Related Content PubMed PubMed Citation Articles by Yeh, H.-M. Articles by Lai, L.-P. Related Collections Complications Technology

---

TECHNOLOGY, COMPUTING, AND SIMULATION

Denaturing High Performance Liquid Chromatography Screening of Ryanodine Receptor Type 1 Gene in Patients with Malignant Hyperthermia in Taiwan and Identification of a Novel Mutation (Y522C)

Huei-Ming Yeh, MD^*, Mei-Chuan Tsai, BS, Yi-Ning Su, MD, Rong-Ching Shen, Jeuy-Jen Hwang, MD, Wei-Zen Sun, MD^*, and Ling-Ping Lai, MD, PhD

Departments of *Anesthesiology, Medical Genetics, and Internal Medicine, National Taiwan University Hospital; and Institute of Pharmacology, National Taiwan University, Taipei, Taiwan

Address correspondence and reprint requests to Dr. Ling-Ping Lai, No. 1, Jen-Ai Rd., Section 1, Institute of Pharmacology, National Taiwan University, Taipei, Taiwan, 100. Address e-mail to lai{at}ha.mc.ntu.edu.tw.

We performed the present study to identify the mutation in patients in Taiwan with malignant hyperthermia (MH). We also test the hypothesis that a denaturing high-performance liquid chromatography (DHPLC) protocol can be used for mutation detection in these patients. We identified five Taiwanese patients with typical clinical presentations of MH after general anesthesia. We also enrolled 50 healthy volunteers. Polymerase chain reaction was used to amplify the ryanodine receptor (RYR1) gene mutation hot spots and DHPLC techniques were used to screen for mutations. Upon detection of a heterozygous elution pattern in DHPLC analysis, DNA sequencing reaction was performed to identify the nucleotide variations. We identified a RYR1 mutation in all 5 patients with MH. There were 4 different mutations in the 5 patients: Tyr522Cys, Arg552Trp, Val2168Met, and Thr2206Arg. Among the 5 patients, 2 unrelated patients had the same Thr2206Arg mutation. Three of the mutations had been reported before, but the Tyr522Cys mutation was novel. None of the MH-related mutations were found in the control group. In conclusion, we identified RYR1 mutations in 5 Taiwanese patients with MH using a DHPLC-based approach. A DHPLC-based genetic test may be developed as a noninvasive and convenient test for MH.

This article has been cited by other articles:

				P.-L. Chen, Y.-W. Chang, C.-Y. Chen, Y.-C. Hsiang, and Y.-J. Day Novel Variants Near the Central Domain of RYR1 in Two Malignant Hyperthermia-Susceptible Families from Taiwan Anesth. Analg., October 1, 2009; 109(4): 1273 - 1277. [Abstract] [Full Text] [PDF]